CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 93 filers reported holding CYTOKINETICS INC in Q1 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,682 | +133.7% | 6,812 | +158.8% | 0.01% | +100.0% |
| Q2 2023 | $85,856 | +67503.1% | 2,632 | -27.1% | 0.00% | -25.0% |
| Q1 2023 | $127 | -78.1% | 3,611 | -71.5% | 0.00% | -83.3% |
| Q4 2022 | $580 | -99.9% | 12,651 | -14.7% | 0.02% | +100.0% |
| Q3 2022 | $718,000 | +24.9% | 14,827 | +1.3% | 0.01% | -7.7% |
| Q2 2022 | $575,000 | +1497.2% | 14,635 | +1398.0% | 0.01% | – |
| Q1 2022 | $36,000 | -89.0% | 977 | -86.4% | 0.00% | -100.0% |
| Q4 2021 | $327,000 | +57.2% | 7,180 | +23.3% | 0.01% | +20.0% |
| Q3 2021 | $208,000 | -33.8% | 5,822 | -63.4% | 0.01% | -37.5% |
| Q2 2021 | $314,000 | +101.3% | 15,903 | +137.9% | 0.01% | +166.7% |
| Q1 2021 | $156,000 | +437.9% | 6,686 | +383.4% | 0.00% | +200.0% |
| Q4 2020 | $29,000 | -62.3% | 1,383 | -61.0% | 0.00% | 0.0% |
| Q3 2020 | $77,000 | -57.2% | 3,547 | -53.6% | 0.00% | -85.7% |
| Q2 2020 | $180,000 | +3500.0% | 7,652 | +1545.6% | 0.01% | – |
| Q1 2020 | $5,000 | +25.0% | 465 | +17.7% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 395 | +182.1% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 140 | -79.0% | 0.00% | – |
| Q4 2018 | $4,000 | -50.0% | 667 | -37.8% | 0.00% | -100.0% |
| Q1 2018 | $8,000 | -80.5% | 1,073 | -78.7% | 0.00% | -80.0% |
| Q4 2017 | $41,000 | +64.0% | 5,028 | +195.6% | 0.01% | +150.0% |
| Q3 2017 | $25,000 | +66.7% | 1,701 | +38.4% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | +150.0% | 1,229 | +158.2% | 0.00% | +100.0% |
| Q4 2016 | $6,000 | +200.0% | 476 | +113.5% | 0.00% | – |
| Q3 2016 | $2,000 | -71.4% | 223 | -68.9% | 0.00% | -100.0% |
| Q2 2016 | $7,000 | -22.2% | 716 | -44.1% | 0.00% | 0.0% |
| Q1 2016 | $9,000 | +800.0% | 1,280 | +635.6% | 0.00% | – |
| Q3 2015 | $1,000 | -96.7% | 174 | -96.1% | 0.00% | -100.0% |
| Q1 2015 | $30,000 | – | 4,437 | +14690.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 30 | -89.5% | 0.00% | – |
| Q2 2014 | $1,000 | -50.0% | 286 | +43.0% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 200 | +14.9% | 0.00% | – |
| Q4 2013 | $1,000 | -94.1% | 174 | -92.4% | 0.00% | -100.0% |
| Q3 2013 | $17,000 | – | 2,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |